OriCiro Genomics is a prominent supplier to the pharmaceutical industry, specialising in the development and commercialisation of cell-free synthesis and amplification technology for genome-scale large DNA. Their innovative approach enhances gene and cell-based therapies and various synthetic biology applications. With a focus on providing powerful tools for research, development, and manufacturing, OriCiro’s proprietary technology holds significant potential across multiple industries, including pharmaceuticals, diagnostics, agriculture, and the food sectors.

Services include:
- Contract manufacturing (CMO/CDMO)
- Plasmid supply
- Custom DNA synthesis
- Gene amplification
- Cell-free protein synthesis

OriCiro Genomics is dedicated to advancing therapeutic solutions and innovative applications in synthetic biology, empowering researchers and practitioners across various fields. For more information, visit oriciro.com.